Loading stock data…
ISRG
$426.61+8.00 (+1.91%)
After Hours$426.12-0.49 (-0.11%)· Last close Jun 9
Intuitive Surgical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Intuitive Surgical, Inc. in the Healthcare sector is trading at $425.45 with a market capitalization of $144.2B. Wall Street consensus targets $565.25 (29 analysts), implying a +32.9% move over the next 12 months. The stock is currently near its 52-week low of $396.68, remaining 13.7% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +32.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$426.61
Potential Upside
48.4%
Whystock Fair Value$633.12
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus29 analysts
Buy
Mean target$565.25+32.5%
Range$366.00 – $750.00
Fundamentals
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Sur...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$144.25B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
49.37
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.51
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
17.05%
Volume
Today's trading volume
2.17M
Recent News
Intuitive Surgical (ISRG) Upgraded to Buy: Here's Why
Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?
ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.
When Investors Finally Get Sick of AI Stocks, This Medical Devices ETF Could Be a Long-Term Winner
Over the long term, the IHI ETF looks like a good turnaround story.
Can Medtronic Finally Challenge Intuitive Surgical's Robotic Surgical Systems Dominance?
Medtronic wants a bite of the robotics-assisted surgery market, which could swell to over $63 billion over the next decade.
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.